The University of Chicago Header Logo

Peter Riedell

Concepts (158)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymphoma, Large B-Cell, Diffuse
19
2023
151
5.520
Why?
Immunotherapy, Adoptive
16
2023
170
2.990
Why?
Hematopoietic Stem Cell Transplantation
11
2023
878
2.240
Why?
Lymphoma, Mantle-Cell
3
2023
35
1.810
Why?
Lymphoma, Non-Hodgkin
5
2023
261
1.390
Why?
Antigens, CD19
10
2023
39
1.360
Why?
Lymphoma, B-Cell
5
2022
103
1.290
Why?
Transplantation, Autologous
6
2021
331
1.060
Why?
Oncologists
1
2023
36
0.910
Why?
Jehovah's Witnesses
1
2021
18
0.770
Why?
Blood Component Removal
1
2020
24
0.770
Why?
Proto-Oncogene Proteins c-myc
2
2018
120
0.770
Why?
Proto-Oncogene Proteins c-bcl-2
2
2018
189
0.750
Why?
Biological Products
4
2023
143
0.730
Why?
Transplantation Conditioning
3
2021
373
0.730
Why?
Neoplasm Recurrence, Local
11
2023
1313
0.700
Why?
Lymphoma
2
2018
262
0.680
Why?
Receptors, Antigen, T-Cell
5
2023
375
0.590
Why?
Antineoplastic Combined Chemotherapy Protocols
7
2023
2438
0.560
Why?
Antibodies, Monoclonal, Murine-Derived
3
2016
78
0.550
Why?
Lymphoma, Follicular
3
2022
70
0.540
Why?
Humans
46
2023
86656
0.530
Why?
Graft vs Host Disease
3
2023
365
0.490
Why?
Hepatitis B virus
1
2014
43
0.490
Why?
Hepatitis B
1
2014
74
0.470
Why?
B-Lymphocytes
1
2017
726
0.440
Why?
Retrospective Studies
9
2023
8476
0.420
Why?
Gene Expression Profiling
1
2017
1387
0.410
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2023
136
0.410
Why?
Antineoplastic Agents, Immunological
2
2023
185
0.360
Why?
Cell- and Tissue-Based Therapy
4
2023
49
0.350
Why?
Antineoplastic Agents
3
2023
2360
0.330
Why?
Prognosis
3
2023
3681
0.320
Why?
T-Lymphocytes
4
2021
1200
0.290
Why?
Sarcopenia
2
2016
13
0.280
Why?
Aged
13
2023
18407
0.270
Why?
Adult
12
2023
25648
0.250
Why?
Oleic Acids
1
2023
26
0.240
Why?
Tumor Lysis Syndrome
1
2023
9
0.230
Why?
Candidiasis
1
2023
36
0.230
Why?
Survival Analysis
3
2023
1540
0.220
Why?
Fluorodeoxyglucose F18
1
2023
138
0.220
Why?
Veterans
4
2016
72
0.210
Why?
Rituximab
4
2016
116
0.210
Why?
Tumor Burden
1
2023
290
0.210
Why?
Middle Aged
11
2022
25027
0.210
Why?
Hodgkin Disease
1
2023
177
0.200
Why?
Geriatric Assessment
2
2020
166
0.200
Why?
Thrombocytopenia
1
2022
183
0.200
Why?
5-Methylcytosine
1
2022
112
0.190
Why?
United States
7
2023
6674
0.190
Why?
Antibodies, Monoclonal, Humanized
2
2023
931
0.180
Why?
Cladribine
1
2019
35
0.180
Why?
CD8-Positive T-Lymphocytes
1
2023
560
0.180
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2020
44
0.180
Why?
Carcinoma
1
2023
436
0.170
Why?
Hematologic Neoplasms
1
2023
329
0.170
Why?
Male
13
2023
40995
0.170
Why?
Patient Selection
2
2019
686
0.170
Why?
Interdisciplinary Communication
1
2019
130
0.170
Why?
Neoplasms
2
2023
2898
0.160
Why?
Female
12
2023
44566
0.150
Why?
Disease Management
1
2019
328
0.150
Why?
Preoperative Care
1
2019
397
0.150
Why?
Patient Care Team
1
2019
280
0.150
Why?
Central Nervous System Neoplasms
1
2018
81
0.150
Why?
Translocation, Genetic
1
2017
265
0.140
Why?
Multiple Myeloma
1
2020
307
0.140
Why?
Cyclophosphamide
4
2021
299
0.140
Why?
Obesity, Abdominal
1
2016
8
0.140
Why?
Remission Induction
3
2023
722
0.140
Why?
Body Composition
1
2016
68
0.140
Why?
Up-Regulation
1
2018
717
0.130
Why?
Recurrence
3
2023
1139
0.130
Why?
Maximum Tolerated Dose
1
2016
270
0.130
Why?
Stem Cell Transplantation
3
2021
183
0.130
Why?
Anthracyclines
1
2015
37
0.130
Why?
Pneumonia, Viral
1
2020
315
0.130
Why?
Coronavirus Infections
1
2020
300
0.130
Why?
Doxorubicin
4
2016
295
0.120
Why?
Survivors
1
2016
227
0.120
Why?
Febrile Neutropenia
1
2014
14
0.120
Why?
Pandemics
1
2020
737
0.120
Why?
Venous Thromboembolism
1
2016
152
0.120
Why?
Heart Failure
1
2023
1207
0.120
Why?
Leukemia, Myeloid, Acute
1
2019
763
0.110
Why?
Transplantation, Homologous
3
2020
996
0.110
Why?
Gene Expression Regulation, Neoplastic
1
2018
1197
0.110
Why?
Clinical Trials as Topic
1
2018
1169
0.110
Why?
Bridged Bicyclo Compounds, Heterocyclic
2
2023
76
0.110
Why?
Time Factors
1
2021
5215
0.110
Why?
Adolescent
2
2023
8988
0.110
Why?
Vincristine
3
2016
111
0.100
Why?
Prednisone
3
2016
258
0.100
Why?
Body Mass Index
1
2014
768
0.100
Why?
Antiviral Agents
1
2014
512
0.090
Why?
Pilot Projects
2
2021
840
0.080
Why?
Antibodies, Monoclonal
1
2014
1380
0.080
Why?
Prospective Studies
3
2023
4212
0.070
Why?
Aged, 80 and over
3
2021
6511
0.060
Why?
Dairy Products
1
2023
11
0.060
Why?
Red Meat
1
2023
10
0.060
Why?
Fatty Acids, Volatile
1
2023
32
0.060
Why?
Cyclic AMP Response Element-Binding Protein
1
2023
66
0.060
Why?
Milk
1
2023
53
0.060
Why?
Sheep
1
2023
243
0.060
Why?
Cyclic AMP-Dependent Protein Kinases
1
2023
108
0.060
Why?
Leukocyte Count
1
2023
220
0.060
Why?
Troponin
1
2023
24
0.060
Why?
Cattle
1
2023
376
0.060
Why?
Cyclic AMP
1
2023
274
0.060
Why?
Melphalan
1
2023
98
0.050
Why?
Outpatients
1
2023
94
0.050
Why?
Immunocompromised Host
1
2023
140
0.050
Why?
C-Reactive Protein
1
2023
190
0.050
Why?
Interleukin-6
1
2023
257
0.050
Why?
Thiotepa
1
2021
32
0.050
Why?
Histiocytes
1
2021
22
0.050
Why?
B7-H1 Antigen
1
2023
250
0.050
Why?
Sulfonamides
1
2023
300
0.050
Why?
Incidence
2
2016
1578
0.050
Why?
Central Nervous System
1
2021
151
0.050
Why?
Treatment Outcome
3
2019
7982
0.050
Why?
Health Planning Guidelines
1
2019
24
0.050
Why?
Chimerism
1
2020
37
0.040
Why?
Filgrastim
1
2019
56
0.040
Why?
Communicable Disease Control
1
2020
50
0.040
Why?
Hydrazines
1
2019
30
0.040
Why?
Health Care Rationing
1
2020
83
0.040
Why?
Health Plan Implementation
1
2019
56
0.040
Why?
Mice
2
2023
11439
0.040
Why?
Triazoles
1
2019
96
0.040
Why?
Cytarabine
1
2019
218
0.040
Why?
Standard of Care
1
2019
79
0.040
Why?
Animals
3
2023
26706
0.040
Why?
Drug Resistance, Neoplasm
1
2021
592
0.040
Why?
Epigenesis, Genetic
1
2022
481
0.040
Why?
Palliative Care
1
2019
257
0.040
Why?
Clinical Decision-Making
1
2019
257
0.040
Why?
Tissue Donors
1
2020
465
0.040
Why?
Steroids
1
2018
176
0.040
Why?
Biomarkers
1
2023
1722
0.040
Why?
Abdominal Fat
1
2016
13
0.040
Why?
Subcutaneous Fat
1
2016
18
0.040
Why?
Neutropenia
1
2016
215
0.030
Why?
Cohort Studies
1
2021
2765
0.030
Why?
Antibiotics, Antineoplastic
1
2015
114
0.030
Why?
Proportional Hazards Models
1
2016
860
0.030
Why?
Muscle, Skeletal
1
2016
450
0.030
Why?
Mice, Inbred C57BL
1
2019
3111
0.030
Why?
Practice Guidelines as Topic
1
2020
1037
0.030
Why?
Longitudinal Studies
1
2016
1019
0.030
Why?
Mutation
1
2022
3977
0.020
Why?
Hospitalization
1
2016
851
0.020
Why?
Young Adult
1
2019
5977
0.020
Why?
Tomography, X-Ray Computed
1
2016
2585
0.020
Why?
Magnetic Resonance Imaging
1
2018
3366
0.020
Why?
Risk Factors
1
2016
5416
0.020
Why?
Riedell's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (158)
Explore
_
Co-Authors (38)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_